These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20693403)
21. Urokinase-type plasminogen activator negatively regulates α-smooth muscle actin expression via Endo180 and the uPA receptor in corneal fibroblasts. Sugioka K; Nishida T; Kodama-Takahashi A; Murakami J; Mano F; Okada K; Fukuda M; Kusaka S Am J Physiol Cell Physiol; 2022 Jul; 323(1):C104-C115. PubMed ID: 35649252 [TBL] [Abstract][Full Text] [Related]
22. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells. Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864 [TBL] [Abstract][Full Text] [Related]
23. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
24. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity. Stillfried GE; Saunders DN; Ranson M Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442 [TBL] [Abstract][Full Text] [Related]
26. [Expression of cellular phenotype switching markers-matrix protein Gla, mRNA and collagen I, III and V of human airway smooth muscle cells in vitro after TGF-beta1 stimulation]. Shao J; Xia ZW; Li YZ; Yu SC; Deng WW Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):531-4. PubMed ID: 17044981 [TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122 [TBL] [Abstract][Full Text] [Related]
28. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes. Kocic J; Bugarski D; Santibanez JF Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735 [TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
31. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226 [TBL] [Abstract][Full Text] [Related]
32. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis. Brauer PR; Yee JA Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842 [TBL] [Abstract][Full Text] [Related]
33. Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-β and potentiates fibrosis. Briassouli P; Rifkin D; Clancy RM; Buyon JP J Immunol; 2011 Nov; 187(10):5392-401. PubMed ID: 22013113 [TBL] [Abstract][Full Text] [Related]
34. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Kuramoto E; Nishiuma T; Kobayashi K; Yamamoto M; Kono Y; Funada Y; Kotani Y; Sisson TH; Simon RH; Nishimura Y Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L337-46. PubMed ID: 19098125 [TBL] [Abstract][Full Text] [Related]
35. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells. Martínez-Rizo A; Bueno-Topete M; González-Cuevas J; Armendáriz-Borunda J Liver Int; 2010 Feb; 30(2):298-310. PubMed ID: 19889106 [TBL] [Abstract][Full Text] [Related]
36. The Coagulant Factor Xa Induces Protease-Activated Receptor-1 and Annexin A2-Dependent Airway Smooth Muscle Cytokine Production and Cell Proliferation. Schuliga M; Royce SG; Langenbach S; Berhan A; Harris T; Keenan CR; Stewart AG Am J Respir Cell Mol Biol; 2016 Feb; 54(2):200-9. PubMed ID: 26120939 [TBL] [Abstract][Full Text] [Related]
37. Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein. George SJ; Johnson JL; Smith MA; Jackson CL J Vasc Res; 2001; 38(5):492-501. PubMed ID: 11561151 [TBL] [Abstract][Full Text] [Related]
38. The fibrogenic actions of lung fibroblast-derived urokinase: a potential drug target in IPF. Schuliga M; Jaffar J; Harris T; Knight DA; Westall G; Stewart AG Sci Rep; 2017 Jan; 7():41770. PubMed ID: 28139758 [TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2. Schuliga M; Javeed A; Harris T; Xia Y; Qin C; Wang Z; Zhang X; Lee PV; Camoretti-Mercado B; Stewart AG Am J Respir Cell Mol Biol; 2013 Mar; 48(3):346-53. PubMed ID: 23239497 [TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-1 and transforming growth factor-beta l promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Albo D; Berger DH; Wang TN; Hu X; Rothman V; Tuszynski GP Surgery; 1997 Aug; 122(2):493-9; discussion 499-500. PubMed ID: 9288157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]